These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 15288832

  • 1. Detection of photodynamic therapy-induced early apoptosis in human salivary gland tumor cells in vitro and in a mouse tumor model.
    Kaneko T, Chiba H, Yasuda T, Kusama K.
    Oral Oncol; 2004 Sep; 40(8):787-92. PubMed ID: 15288832
    [Abstract] [Full Text] [Related]

  • 2. Use of the monoclonal antibody M30 for detecting HSG cell apoptosis.
    Kusama K, Jiang Y, Toguchi M, Ohno J, Shikata H, Sakashita H, Sakagami H.
    Anticancer Res; 2000 Sep; 20(1A):151-4. PubMed ID: 10769647
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic effect of photodynamic therapy using PAD-S31 and diode laser on human liver cancer cells.
    Date M, Fukuchi K, Namiki Y, Okumura A, Morita S, Takahashi H, Ohura K.
    Liver Int; 2004 Apr; 24(2):142-8. PubMed ID: 15078479
    [Abstract] [Full Text] [Related]

  • 4. Photodynamic therapy with mono-L-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: experimental study on an animal model of nude mouse.
    Kobayashi W, Liu Q, Nakagawa H, Sakaki H, Teh B, Matsumiya T, Yoshida H, Imaizumi T, Satoh K, Kimura H.
    Oral Oncol; 2006 Jan; 42(1):46-50. PubMed ID: 16266818
    [Abstract] [Full Text] [Related]

  • 5. Photodynamic therapy for human oral squamous cell carcinoma and xenografts using a new photosensitizer, PAD-S31.
    Date M, Sakata I, Fukuchi K, Ohura K, Azuma Y, Shinohara M, Matsuzaki K, Namiki Y, Takahashi H.
    Lasers Surg Med; 2003 Jan; 33(1):57-63. PubMed ID: 12866122
    [Abstract] [Full Text] [Related]

  • 6. Photodynamic therapy with the phthalocyanine photosensitizer Pc 4 of SW480 human colon cancer xenografts in athymic mice.
    Whitacre CM, Feyes DK, Satoh T, Grossmann J, Mulvihill JW, Mukhtar H, Oleinick NL.
    Clin Cancer Res; 2000 May; 6(5):2021-7. PubMed ID: 10815928
    [Abstract] [Full Text] [Related]

  • 7. Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model.
    Ferrario A, Kessel D, Gomer CJ.
    Cancer Res; 1992 May 15; 52(10):2890-3. PubMed ID: 1581904
    [Abstract] [Full Text] [Related]

  • 8. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model.
    Engbrecht BW, Menon C, Kachur AV, Hahn SM, Fraker DL.
    Cancer Res; 1999 Sep 01; 59(17):4334-42. PubMed ID: 10485481
    [Abstract] [Full Text] [Related]

  • 9. High expression of GADD-45alpha and VEGF induced tumor recurrence via upregulation of IL-2 after photodynamic therapy using NPe6.
    Ohtani K, Usuda J, Ichinose S, Ishizumi T, Hirata T, Inoue T, Maehara S, Imai K, Kubota M, Tsunoda Y, Yamada M, Tsutsui H, Yamada K, Kuroiwa Y, Furukawa K, Okunaka T, Kato H.
    Int J Oncol; 2008 Feb 01; 32(2):397-403. PubMed ID: 18202762
    [Abstract] [Full Text] [Related]

  • 10. Studies on preparation and photodynamic mechanism of chlorin P6-13,15-N-(cyclohexyl)cycloimide (Chlorin-H) and its antitumor effect for photodynamic therapy in vitro and in vivo.
    Yan YJ, Zheng MZ, Chen ZL, Yu XH, Yang XX, Ding ZL, Xu L.
    Bioorg Med Chem; 2010 Sep 01; 18(17):6282-91. PubMed ID: 20691601
    [Abstract] [Full Text] [Related]

  • 11. Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.
    Colussi VC, Feyes DK, Mulvihill JW, Li YS, Kenney ME, Elmets CA, Oleinick NL, Mukhtar H.
    Photochem Photobiol; 1999 Feb 01; 69(2):236-41. PubMed ID: 10048316
    [Abstract] [Full Text] [Related]

  • 12. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model.
    Wong Kee Song LM, Wang KK, Zinsmeister AR.
    Cancer; 1998 Jan 15; 82(2):421-7. PubMed ID: 9445202
    [Abstract] [Full Text] [Related]

  • 13. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model.
    Gomer CJ, Ferrario A.
    Cancer Res; 1990 Jul 01; 50(13):3985-90. PubMed ID: 2354446
    [Abstract] [Full Text] [Related]

  • 14. CHOP activation by photodynamic therapy increases treatment induced photosensitization.
    Wong S, Luna M, Ferrario A, Gomer CJ.
    Lasers Surg Med; 2004 Jul 01; 35(5):336-41. PubMed ID: 15611953
    [Abstract] [Full Text] [Related]

  • 15. Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizer.
    Takeuchi Y, Kurohane K, Ichikawa K, Yonezawa S, Nango M, Oku N.
    Cancer; 2003 Apr 15; 97(8):2027-34. PubMed ID: 12673734
    [Abstract] [Full Text] [Related]

  • 16. Hypericin-mediated photodynamic therapy induces lipid peroxidation and necrosis in nasopharyngeal cancer.
    Du HY, Olivo M, Tan BK, Bay BH.
    Int J Oncol; 2003 Nov 15; 23(5):1401-5. PubMed ID: 14532982
    [Abstract] [Full Text] [Related]

  • 17. Analysis of apoptotic effects induced by photodynamic therapy in a human biliary cancer cell line.
    Nonaka T, Nanashima A, Nonaka M, Uehara M, Isomoto H, Asahina I, Nagayasu T.
    Anticancer Res; 2010 Jun 15; 30(6):2113-8. PubMed ID: 20651359
    [Abstract] [Full Text] [Related]

  • 18. Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT.
    Thong PS, Watt F, Ren MQ, Tan PH, Soo KC, Olivo M.
    J Photochem Photobiol B; 2006 Jan 02; 82(1):1-8. PubMed ID: 16203156
    [Abstract] [Full Text] [Related]

  • 19. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
    Kirveliene V, Grazeliene G, Dabkeviciene D, Micke I, Kirvelis D, Juodka B, Didziapetriene J.
    Cancer Chemother Pharmacol; 2006 Jan 02; 57(1):65-72. PubMed ID: 16001168
    [Abstract] [Full Text] [Related]

  • 20. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L, Garris BL, Garris DR, Lau YS.
    Neuroscience; 2006 Jun 19; 140(1):67-76. PubMed ID: 16533572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.